What it is
Regulatory status: dietary supplement ingredient; not an FDA-approved insomnia treatment
Mechanism evidence: hypothesis
GABA is the nervous system's main inhibitory neurotransmitter, but it is uncertain how much orally ingested GABA reaches the human brain. Small studies report stress or sleep signals through possible central or peripheral pathways.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: dietary supplement ingredient; not an FDA-approved insomnia treatment
Mechanism evidence: hypothesis
Oral GABA has a small and heterogeneous human evidence base. Some studies suggest stress or sleep effects, but brain penetration, effective dose and long-term safety remain uncertain; it is not a proven insomnia treatment.
Confidence: weak
Known side effects, interactions and use limits from reviewed sources.
Short studies report few serious events, but long-term and high-dose safety data are limited. Sedation may add to alcohol, sleep medicines or other central nervous system depressants; pregnancy and breastfeeding data are inadequate.
This review does not automatically apply to:
Public protocols that include GABA. Open one to see the full context and source.
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
GABA is listed as an ingredient or component in these reviewed interventions.
Continue into interventions that appear alongside this one.